Measles virus recombinant poxvirus vaccine
CA 2096633 A1 · Owner: Taylor, Jill · Inventors: Taylor, Jill; Paoletti, Enzo
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
What is described is a recombinant poxvirus such as vaccinia, virus or canarypox virus containing foreign DNA from Morbillivirus. In one embodiment the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 20, 1991. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 20, 2011.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 20, 2013.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.